Cargando…

The Cellular and Humoral Immune Response to SARS-CoV-2 Messenger RNA Vaccines Is Significantly Better in Liver Transplant Patients Compared with Kidney Transplant Patients

Patients after organ transplantation have impaired immune response after vaccination against the SARS-CoV-2 virus. So far, published studies have reported quite different response rates to SARS-CoV-2 vaccination, ranging from 15–79% in liver and kidney transplant recipients. Up to one year after the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lautem, Anja, Boedecker-Lips, Simone Cosima, Schneider, Elisa, Runkel, Stefan, Feist, Christina, Lang, Hauke, Weinmann-Menke, Julia, Koch, Martina
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10383075/ https://www.ncbi.nlm.nih.gov/pubmed/37513757 http://dx.doi.org/10.3390/pathogens12070910

Ejemplares similares

Six-Month Follow-Up after Vaccination with BNT162b2: SARS-CoV-2 Antigen-Specific Cellular and Humoral Immune Responses in Hemodialysis Patients and Kidney Transplant Recipients
por: Boedecker-Lips, Simone Cosima, et al.
Publicado: (2022)

COVID-19—Importance for Patients on the Waiting List and after Kidney Transplantation—A Single Center Evaluation in 2020–2021
por: Boedecker, Simone C., et al.
Publicado: (2021)

Validation of the 2019 EULAR/ACR classification criteria for systemic lupus erythematosus in an academic tertiary care centre
por: Schmidtmann, Irene, et al.
Publicado: (2023)

Plasma exchange for treatment of a therapy‐related thrombotic microangiopathy in a patient with advanced hepatocellular carcinoma—A case report
por: Stortz, Marco, et al.
Publicado: (2023)

Comment on “Heterologous adenovirus‐vector/messenger RNA regimen, humoral response and liver transplant recipients”
por: Sookaromdee, Pathum, et al.
Publicado: (2022)

Comparison of Humoral and Cellular CMV Immunity in Patients Awaiting Kidney Transplantation
por: Lindemann, Monika, et al.
Publicado: (2021)

Elderly Patients with Hepatocellular Carcinoma Benefit from Liver Transplantation as Much as Younger Ones
por: Mittler, Jens, et al.
Publicado: (2022)

Chemokine Receptor-5Δ32 Mutation is No Risk Factor for Ischemic-Type Biliary Lesion in Liver Transplantation
por: Heidenhain, Christoph, et al.
Publicado: (2009)

Case Report: Kinetics and durability of humoral and cellular response of SARS-CoV-2 messenger RNA vaccine in a lung and kidney transplant recipient
por: Long, James, et al.
Publicado: (2023)

The Humoral Theory of Transplantation
por: Ravindranath, Mepur H., et al.
Publicado: (2017)

Humoral and cellular immune response after severe acute respiratory syndrome coronavirus 2 messenger ribonucleic acid vaccination in heart transplant recipients: An observational study in France
por: Casenaz, Alice, et al.
Publicado: (2022)

Twelve-Week Internet-Based Individualized Exercise Program in Adults With Systemic Lupus Erythematosus: Protocol for a Randomized Controlled Trial
por: Boedecker, Simone Cosima, et al.
Publicado: (2020)

Effectiveness of Messenger Ribonucleic Acid Vaccine in Lung Transplant Recipients
por: Vender, R.J., et al.
Publicado: (2022)

mTOR inhibitors improve both humoral and cellular response to SARS-CoV-2 messenger RNA BNT16b2 vaccine in kidney transplant recipients
por: Netti, Giuseppe S., et al.
Publicado: (2022)

Humoral and cellular immunogenicity two months after SARS-CoV-2 messenger RNA vaccines in patients with cancer
por: Bordry, Natacha, et al.
Publicado: (2021)

Heterologous adenovirus‐vector/messenger RNA regimen is associated with improved severe acute respiratory syndrome coronavirus 2 humoral response in liver transplant recipients
por: Mendizabal, Manuel, et al.
Publicado: (2022)

Influence of Advanced Organ Support (ADVOS) on Cytokine Levels in Patients with Acute-on-Chronic Liver Failure (ACLF)
por: Kaps, Leonard, et al.
Publicado: (2022)

Poor humoral and T-cell response to two-dose SARS-CoV-2 messenger RNA vaccine BNT162b2 in cardiothoracic transplant recipients
por: Schramm, René, et al.
Publicado: (2021)

Cellular and Humoral Immunity against Different SARS-CoV-2 Variants Is Detectable but Reduced in Vaccinated Kidney Transplant Patients
por: Thümmler, Laura, et al.
Publicado: (2022)

Humoral Immune Response to Messenger RNA COVID-19 Vaccines Among Patients With Inflammatory Bowel Disease
por: Kappelman, Michael D., et al.
Publicado: (2021)

Kidney transplantation in patients with diabetes: better than nothing
por: Kim, Chang Seong
Publicado: (2018)

Antibody response to the messenger RNA‐1273 vaccine (Moderna) in liver transplant recipients
por: Cuadrado, Antonio, et al.
Publicado: (2022)

Metabolic intermediates – Cellular messengers talking to chromatin modifiers
por: Nieborak, Anna, et al.
Publicado: (2018)

Validation of insulin-like growth factor-1 as a prognostic parameter in patients with hepatocellular carcinoma in a European cohort
por: Huber, Yvonne, et al.
Publicado: (2018)

Humoral and cellular immune correlates of protection against COVID-19 in kidney transplant recipients
por: Kemlin, Delphine, et al.
Publicado: (2023)

Impaired Humoral and Cellular Responses to COVID-19 Vaccine in Heart and Lung Transplant Recipients
por: Gerovasili, Vicky, et al.
Publicado: (2022)

Use of Bortezomib as Anti-Humoral Therapy in Kidney Transplantation
por: Yang, Keun Suk, et al.
Publicado: (2014)

Cardiohepatic Interactions - from Humoral Theory to Organ Transplantation
por: Silvestre, Odilson Marcos, et al.
Publicado: (2014)

Association of serum neurofilament light chain levels and neuropsychiatric manifestations in systemic lupus erythematosus
por: Engel, Sinah, et al.
Publicado: (2021)

Drug Interaction between Sirolimus and Ranolazine in a Kidney Transplant Patient
por: Masters, Joanna C., et al.
Publicado: (2014)

Comparing Humoral and Cellular Adaptive Immunity during Convalescent Phase of COVID-19 in Hemodialysis Patients and Kidney Transplant Recipients
por: Kamińska, Dorota, et al.
Publicado: (2021)

Humoral and cellular response after BNT162b2 vaccine booster in hemodialysis patients and kidney transplant recipients
por: De Cagna, Maria Rosaria, et al.
Publicado: (2023)

Validating quantitative PCR assays for cfDNA detection without DNA extraction in exercising SLE patients
por: Neuberger, Elmo W. I., et al.
Publicado: (2021)

Kinetics of cellular and humoral responses to third COVID-19 vaccine in heart transplant recipients: Correspondence
por: Sokaromdee, Pathum, et al.
Publicado: (2022)

Evaluation of the Humoral and Cellular Immune Response Post COVID-19 Infection in Kidney Transplant Recipients
por: Bensaid, Kahina, et al.
Publicado: (2023)

Antibody response to the messenger RNA corona virus disease 2019 vaccine in liver transplant recipients
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2022)

Humoral Alloimmunity in Transplantation: Relevance of HLA Epitope Antigenicity and Immunogenicity
por: Duquesnoy, René J.
Publicado: (2011)

The Humoral Theory of Transplantation: Epitope Analysis and the Pathogenicity of HLA Antibodies
por: Filippone, Edward J., et al.
Publicado: (2016)

From Humoral Theory to Performant Risk Stratification in Kidney Transplantation
por: Lefaucheur, C., et al.
Publicado: (2017)

Data regarding transplant induced germinal center humoral autoimmunity
por: Qureshi, M. Saeed, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_uq156srjigm8qu58oskic7rkh9